EIEMX
Price
$14.62
Change
-$0.03 (-0.20%)
Updated
Nov 13 closing price
VEIEX
Price
$28.92
Change
-$0.19 (-0.65%)
Updated
Nov 13 closing price
Ad is loading...

EIEMX vs VEIEX

Header iconEIEMX vs VEIEX Comparison
Open Charts EIEMX vs VEIEXBanner chart's image
Parametric Emerging Markets I
Price$14.62
Change-$0.03 (-0.20%)
VolumeN/A
CapitalizationN/A
Vanguard Emerging Mkts Stock Idx I
Price$28.92
Change-$0.19 (-0.65%)
VolumeN/A
CapitalizationN/A
EIEMX vs VEIEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EIEMX vs. VEIEX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EIEMX is a Hold and VEIEX is a Sell.

FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 113B vs. EIEMX (187M). VEIEX pays higher dividends than EIEMX: VEIEX (3.27) vs EIEMX (2.92). EIEMX was incepted earlier than VEIEX: EIEMX (18 years) vs VEIEX (31 years). EIEMX (5.00) and VEIEX (5.00) have comparable annual turnover. VEIEX has a lower initial minimum investment than EIEMX: VEIEX (0) vs EIEMX (1000000). VEIEX annual gain was more profitable for investors over the last year : 18.77 vs. EIEMX (14.66). VEIEX return over 5 years is better than : 19.04 vs. EIEMX (14.25).
EIEMXVEIEXEIEMX / VEIEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence18 years31 years-
Gain YTD7.24712.26259%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets187M113B0%
Annual Yield % from dividends2.923.2789%
Returns for 1 year14.6618.7778%
Returns for 3 years-0.65-6.0611%
Returns for 5 years14.2519.0475%
Returns for 10 years8.0127.5329%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CARA0.34N/A
N/A
Cara Therapeutics
PPL33.24-0.22
-0.66%
PPL Corp
PI194.54-4.76
-2.39%
Impinj
VNET3.48-0.10
-2.92%
VNET Group
CRBP17.94-0.65
-3.50%
Corbus Pharmaceuticals Holdings